ABL1 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
ABL1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
Purified recombinant protein of Human c-abl oncogene 1, non-receptor tyrosine kinase (ABL1), transcript variant b,Arg893-Lys966, with N-terminal His-ABP tag, expressed in E. coli, 50ug
| Tag | N-His-ABP (Albumin-Binding Protein) |
| Expression Host | E. coli |
ABL1 CRISPRa kit - CRISPR gene activation of human ABL proto-oncogene 1, non-receptor tyrosine kinase
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
ABL1 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRFP-C-RS |
ABL1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
3' UTR clone of c-abl oncogene 1 receptor tyrosine kinase (ABL1) transcript variant a for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
3' UTR clone of c-abl oncogene 1 receptor tyrosine kinase (ABL1) transcript variant b for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
qSTAR qPCR primer pairs against Homo sapiens gene ABL1
United States
Germany
Japan
United Kingdom
China
